Follow
Xavier Barbeau
Xavier Barbeau
NuChem Sciences
Verified email at nuchemsciences.com
Title
Cited by
Cited by
Year
Efficient restoration of the dystrophin gene reading frame and protein structure in DMD myoblasts using the CinDel method
JP Iyombe-Engembe, DL Ouellet, X Barbeau, J Rousseau, ...
Molecular Therapy-Nucleic Acids 5, 2016
962016
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia
S Krishnamurthy, C Wohlford-Lenane, S Kandimalla, G Sartre, ...
Nature communications 10 (1), 4906, 2019
942019
Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells
T Del’Guidice, JP Lepetit-Stoffaes, LJ Bordeleau, J Roberge, V Théberge, ...
PloS one 13 (4), e0195558, 2018
822018
CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo
BL Duchêne, K Cherif, JP Iyombe-Engembe, A Guyon, J Rousseau, ...
Molecular Therapy 26 (11), 2604-2616, 2018
732018
Stereocontrolled approach to bromofluoroalkenes and their use for the synthesis of tri-and tetrasubstituted fluoroalkenes
G Landelle, PA Champagne, X Barbeau, JF Paquin
Organic Letters 11 (3), 681-684, 2009
652009
Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-(m-carbamoylbenzyl)-estradiol Derivatives
R Maltais, D Ayan, A Trottier, X Barbeau, P Lagüe, JE Bouchard, ...
Journal of medicinal chemistry 57 (1), 204-222, 2014
432014
Quinazoline‐4‐piperidine sulfamides are specific inhibitors of human NPP 1 and prevent pathological mineralization of valve interstitial cells
EE Shayhidin, E Forcellini, MC Boulanger, A Mahmut, S Dautrey, ...
British journal of pharmacology 172 (16), 4189-4199, 2015
392015
Viral polymerase inhibitors
T Stammers, X Barbeau, P Beaulieu, M Bertrand-laperle, C Brochu, ...
US Patent App. 12/883,677, 2011
342011
Antibiotic resistance due to an unusual ColE1-type replicon plasmid in Aeromonas salmonicida
AT Vincent, JG Emond-Rheault, X Barbeau, SA Attéré, M Frenette, ...
Microbiology 162 (6), 942-953, 2016
332016
Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties
C Ouellet, R Maltais, É Ouellet, X Barbeau, P Lagüe, D Poirier
European Journal of Medicinal Chemistry 119, 169-182, 2016
302016
Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1
E Forcellini, S Boutin, CA Lefebvre, EE Shayhidin, MC Boulanger, ...
European Journal of Medicinal Chemistry 147, 130-149, 2018
252018
Interfacial supramolecular biomimetic epoxidation catalysed by cyclic dipeptides
C Berube, X Barbeau, S Cardinal, PL Boudreault, C Bouchard, N Delcey, ...
Supramolecular Chemistry 29 (5), 330-349, 2017
242017
Revisiting the Juliá–Colonna enantioselective epoxidation: supramolecular catalysis in water
C Bérubé, X Barbeau, P Lagüe, N Voyer
Chemical communications 53 (37), 5099-5102, 2017
212017
Extended linkers improve the detection of protein-protein interactions (PPIs) by dihydrofolate reductase protein-fragment complementation assay (DHFR PCA) in living cells
AÈ Chrétien, I Gagnon-Arsenault, AK Dubé, X Barbeau, PC Després, ...
Molecular & Cellular Proteomics 17 (2), 373-383, 2018
192018
Impact of structural modifications at positions 13, 16 and 17 of 16β-(m-carbamoylbenzyl)-estradiol on 17β-hydroxysteroid dehydrogenase type 1 inhibition and estrogenic activity
R Maltais, A Trottier, X Barbeau, P Laguee, M Perreault, JF Theriault, ...
The journal of steroid biochemistry and molecular biology 161, 24-35, 2016
192016
Identification of fused 16β, 17β-oxazinone-estradiol derivatives as a new family of non-estrogenic 17β-hydroxysteroid dehydrogenase type 1 inhibitors
R Maltais, A Trottier, A Delhomme, X Barbeau, P Lagüe, D Poirier
European Journal of Medicinal Chemistry 93, 470-480, 2015
182015
Insight into the mode of action and selectivity of PBRM, a covalent steroidal inhibitor of 17β-hydroxysteroid dehydrogenase type 1
A Trottier, R Maltais, D Ayan, X Barbeau, J Roy, M Perreault, R Poulin, ...
Biochemical pharmacology 144, 149-161, 2017
172017
Aeromonas salmonicida Ati2 is an effector protein of the type three secretion system
S Dallaire-Dufresne, X Barbeau, D Sarty, KH Tanaka, AM Denoncourt, ...
Microbiology 159 (Pt_9), 1937-1945, 2013
172013
Novel chiral N, N′-dimethyl-1, 4-piperazines with metal binding abilities
C Bérubé, S Cardinal, PL Boudreault, X Barbeau, N Delcey, M Giguère, ...
Tetrahedron 71 (42), 8077-8084, 2015
152015
Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ
C Carpentier, X Barbeau, J Azelmat, K Vaillancourt, D Grenier, P Lagüe, ...
Bioorganic & Medicinal Chemistry 26 (22), 5845-5851, 2018
142018
The system can't perform the operation now. Try again later.
Articles 1–20